Biochemistry Department, Faculty of Pharmacy, Ahram Canadian University, 4th industrial region, 6th of October City, 12585, Giza, Egypt.
Biochemistry Department, Faculty of Pharmacy for Girls, Al-Azhar University, Cairo, 11651, Egypt.
Clin Transl Oncol. 2021 Jul;23(7):1440-1451. doi: 10.1007/s12094-020-02542-0. Epub 2021 Jan 12.
Altered miRNAs play a crucial role in the emergence of the breast cancer stem cell (BCSC) phenotype. The interplay between miRNAs and methylation enzymes has been documented. One of the most aggressive breast cancer cell lines, MDA-MB-231, has expressed much more DNMT3B than DNMT3A. This study aims to evaluate the ability of miR-203 restoration and miR-150 inhibition to regulate DNMT3B and DNMT3A to modify the methylation level of BCSC-associated genes.
MDA-MB-231 cells were transfected with miR-203 mimic or miR-150 inhibitor or DNMT3B siRNA, and downstream analysis was performed by flow cytometry, real-time PCR and Western blotting.
DNMT3A and DNMT3B are regulated both by miR-203a-3p and miR-150-5p. Transfection with miR-203 mimic and miR-150 inhibitor significantly reduced the CD44CD24 subpopulation and down-regulated the expression of CD44 mRNA by increasing promoter methylation levels. SiRNA knockdown of DNMT3B increased the CD44CD24 subpopulation and the expression of CD44 and ALDH1A3 by decreasing methylation density. The inhibition of miR-150 down-regulated OCT3/4 and SOX2 expression without affecting methylation levels, while miR-203 restoration and miR-150 inhibition down-regulated NANOG expression by elevating the methylation level. A positive-feedback loop was found between miR-203 and its target DNMT3B, as restoring miR-203 suppressed DNMT3B, while knocking down DNMT3B up-regulated miR-203. The restoration of miR-203 and knockdown of DNMT3B decreased methylation levels and increased the expression of miR-141 and miR-200c.
The study concluded that miR-203 and miR-150 play a role in the regulation of genes involved in BCSC methylation, including other miRNAs, by targeting DNMT3B and DNMT3A.
改变的 miRNAs 在乳腺癌干细胞(BCSC)表型的出现中起着关键作用。miRNAs 与甲基化酶之间的相互作用已有记录。其中一种最具侵袭性的乳腺癌细胞系 MDA-MB-231 表达的 DNMT3B 比 DNMT3A 多得多。本研究旨在评估 miR-203 恢复和 miR-150 抑制调节 DNMT3B 和 DNMT3A 以修饰与 BCSC 相关基因的甲基化水平的能力。
MDA-MB-231 细胞用 miR-203 模拟物或 miR-150 抑制剂或 DNMT3B siRNA 转染,通过流式细胞术、实时 PCR 和 Western blot 进行下游分析。
DNMT3A 和 DNMT3B 均受 miR-203a-3p 和 miR-150-5p 调节。miR-203 模拟物和 miR-150 抑制剂的转染显著降低了 CD44CD24 亚群,并通过增加启动子甲基化水平降低了 CD44 mRNA 的表达。DNMT3B 的 siRNA 敲低增加了 CD44CD24 亚群,并通过降低甲基化密度增加了 CD44 和 ALDH1A3 的表达。miR-150 的抑制降低了 OCT3/4 和 SOX2 的表达而不影响甲基化水平,而 miR-203 的恢复和 miR-150 的抑制通过提高甲基化水平降低了 NANOG 的表达。发现 miR-203 与其靶标 DNMT3B 之间存在正反馈回路,因为恢复 miR-203 抑制了 DNMT3B,而敲低 DNMT3B 上调了 miR-203。miR-203 的恢复和 DNMT3B 的敲低降低了甲基化水平并增加了 miR-141 和 miR-200c 的表达。
该研究得出结论,miR-203 和 miR-150 通过靶向 DNMT3B 和 DNMT3A 在调节与 BCSC 甲基化相关的基因表达中发挥作用,包括其他 miRNAs。